Doximity Inc (DOCS)vsVeeva Systems Inc Class A (VEEV)
DOCS
Doximity Inc
$34.25
+3.04%
HEALTHCARE · Cap: $5.52B
VEEV
Veeva Systems Inc Class A
$317.82
+1.39%
HEALTHCARE · Cap: $50.25B
Smart Verdict
WallStSmart Research — data-driven comparison
Veeva Systems Inc Class A generates 427% more annual revenue ($3.46B vs $655.57M). VEEV leads profitability with a 29.3% profit margin vs 25.5%. DOCS appears more attractively valued with a PEG of 0.59. VEEV earns a higher WallStSmart Score of 66/100 (B-).
DOCS
Buy57
out of 100
Grade: C
VEEV
Strong Buy66
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+49.3%
Fair Value
$51.22
Current Price
$34.25
$16.97 discount
Margin of Safety
+41.0%
Fair Value
$299.84
Current Price
$317.82
$17.98 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Every $100 of equity generates 21 in profit
Keeps 26 of every $100 in revenue as profit
Growing faster than its price suggests
Strong operational efficiency at 21.5%
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Large-cap with strong market position
Keeps 29 of every $100 in revenue as profit
Strong operational efficiency at 29.6%
17.6% revenue growth
Areas to Watch
Premium valuation, high expectations priced in
Weak financial health signals
Earnings declined 51.9%
Premium valuation, high expectations priced in
Comparative Analysis Report
WallStSmart ResearchBull Case : DOCS
The strongest argument for DOCS centers on Debt/Equity, Altman Z-Score, Return on Equity. Profitability is solid with margins at 25.5% and operating margin at 21.5%. PEG of 0.59 suggests the stock is reasonably priced for its growth.
Bull Case : VEEV
The strongest argument for VEEV centers on Debt/Equity, Altman Z-Score, Market Cap. Profitability is solid with margins at 29.3% and operating margin at 29.6%. Revenue growth of 17.6% demonstrates continued momentum.
Bear Case : DOCS
The primary concerns for DOCS are P/E Ratio, Piotroski F-Score, EPS Growth.
Bear Case : VEEV
The primary concerns for VEEV are P/E Ratio. A P/E of 50.9x leaves little room for execution misses.
Key Dynamics to Monitor
DOCS profiles as a mature stock while VEEV is a growth play — different risk/reward profiles.
DOCS carries more volatility with a beta of 1.22 — expect wider price swings.
VEEV is growing revenue faster at 17.6% — sustainability is the question.
VEEV generates stronger free cash flow (231M), providing more financial flexibility.
Bottom Line
VEEV scores higher overall (66/100 vs 57/100), backed by strong 29.3% margins and 17.6% revenue growth. DOCS offers better value entry with a 49.3% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Doximity Inc
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Doximity, Inc. (Ticker: DOCS) is a U.S. healthcare technology company that operates a digital platform tailored for medical professionals. The company’s cloud-based network provides secure communication and collaboration tools, telemedicine services, clinical workflow solutions, and access to medical news, research, and career-management features for physicians, nurse practitioners, physician assistants, and other clinicians. Headquartered in San Francisco, California, Doximity’s Class A common stock trades on the New York Stock Exchange under the ticker DOCS.
Veeva Systems Inc Class A
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America. The company is headquartered in Pleasanton, California.
Visit Website →Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?